Table 3.
Prescribing question responses for cohort overall
| Prescribing arm | Pathology arm | Imaging arm | ||||
|---|---|---|---|---|---|---|
| Baseline N = 22 | End N = 11 | Baseline N = 20 | End N = 12 | Baseline N = 18 | End N = 14 | |
| Deprescribing confidence | ||||||
| 1—not confident | 2 (9.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (5.6%) | 0 (0.0%) |
| 2 | 4 (18.2%) | 0 (0.0%) | 4 (20.0%) | 0 (0.0%) | 1 (5.6%) | 0 (0.0%) |
| 3 | 10 (45.5%) | 1 (9.1%) | 9 (45.0%) | 4 (33.3%) | 9 (50.0%) | 5 (35.7%) |
| 4 | 5 (22.7%) | 7 (63.6%) | 5 (25.0%) | 6 (50.0%) | 7 (38.8%) | 6 (42.9%) |
| 5—extremely confident | 1 (4.5%) | 3 (27.3%) | 2 (10.0%) | 2(16.7%) | 0 (0.0%) | 3 (21.4%) |
| Deprescribing discussions | ||||||
| 0 times | 0 (0.0%) | 0 (0.0%) | 1 (5.0%) | 0 (0.0%) | 1 (5.6%) | 0 (0.0%) |
| 1–5 times | 10 (45.4%) | 0 (0.0%) | 6 (30.0%) | 3 (25.0%) | 5 (27.8%) | 2 (14.3%) |
| 6–10 times | 8 (36.4%) | 5 (45.4%) | 8 (40.0%) | 3 (25.0%) | 7 (38.9%) | 7 (50.0%) |
| 11–15 times | 2 (9.1%) | 3 (27.3%) | 4 (20.0%) | 3 (25.0%) | 3 (16.6%) | 3 (21.4%) |
| 16 + times | 2 (9.1%) | 3 (27.3%) | 1 (5.0%) | 3 (25.0%) | 2 (11.1%) | 2 (14.3%) |
| Deprescribing frequency | ||||||
| 0 times | 2 (9.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| 1–5 times | 8 (36.4%) | 2 (18.2%) | 11 (55.0%) | 2 (16.7%) | 7 (38.9%) | 3 (21.4%) |
| 6–10 times | 7 (31.8%) | 5 (45.4%) | 4 (20.0%) | 7 (58.3%) | 4 (22.2%) | 6 (42.9%) |
| 11–15 times | 3 (13.6%) | 3 (27.3%) | 2 (10.0%) | 0 (0.0%) | 5 (27.8%) | 2 (14.3%) |
| 16 + times | 2 (9.1%) | 1 (9.1%) | 3 (15.0%) | 3 (25.0%) | 2 (11.1%) | 30 (21.4%) |